Skip to main content
SpringerLink
Log in

Prostate Cancer

  • Chapter
  • First Online:
Book cover Re-Irradiation: New Frontiers

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 1284 Accesses

Abstract

Salvage radiotherapy for locally recurrent prostate cancer after primary radiation is generally performed using brachytherapy. Only a limited amount of small studies has been performed so far. In these studies the rate of severe toxicity, requiring operative reintervention, was high and cancer control outcome was disappointing. Furthermore, it is unclear whether salvage treatment will improve disease-specific or overall survival. For these reasons, salvage brachytherapy is not popular and usually only performed in large tertiary centers. Salvage can currently be considered in patients with a pathology-proven local recurrence with an interval of at least 2–3 years after primary treatment, together with a limited and nonaggressive tumor presentation at time of salvage. Currently, experienced groups recommend at least equal doses used in primary treatment, together with targeting the entire prostate. Diagnostic developments in magnetic resonance imaging (MRI) and positron emission tomography (PET) and biopsy techniques such as transperineal and MRI-targeted biopsies provide the possibility to localize the macroscopic recurrent tumor in the prostate. This enables a shift to focal salvage techniques which can be expected to reduce severe toxicity rates while maintaining cancer control.

The original version of this chapter was revised. An erratum to this chapter can be found at 10.1007/978-3-319-41825-4_78.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abuzallouf S, Dayes I, Lukka H (2004) Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol 171:2122–2127

    Article  PubMed  Google Scholar 

  • Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR (2008) Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 112:307–314

    Article  PubMed  Google Scholar 

  • Ahmed HU, Cathcart P, McCartan N et al (2012) Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy: a pilot study. Cancer 118:4148–4155

    Article  PubMed  Google Scholar 

  • Akyol F, Ozyigit G, Selek U et al (2005) PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone. Eur Urol 48:40–45

    Article  CAS  PubMed  Google Scholar 

  • Alongi F, De Bari B, Campostrini F et al (2013) Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review. Crit Rev Oncol Hematol 88:550–563

    Article  PubMed  Google Scholar 

  • American Society for Therapeutic Radiology and Oncology Consensus Panel (1997) Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys. 37:1035–1041

    Google Scholar 

  • Arrayeh E, Westphalen AC, Kurhanewicz J et al (2012) Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. Int J Radiat Oncol Biol Phys 82:787–793

    Article  Google Scholar 

  • Baco E, Gelet A, Crouzet S et al (2014) Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study. BJU Int 114:532–540

    Article  PubMed  Google Scholar 

  • Bahn DK, Lee F, Silverman P et al (2003) Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer 2:111–114

    Article  PubMed  Google Scholar 

  • Barentsz JO, Fütterer JJ, Takahashi S (2007) Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients. Eur J Radiol 63:369–372

    Article  PubMed  Google Scholar 

  • Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22:746–757

    Article  PubMed  PubMed Central  Google Scholar 

  • Barzell WE, Whitmore WF (2003) Transperineal template guided saturation biopsy of the prostate: rationale, indications, and technique. Urol Times 31:41–42

    Google Scholar 

  • Battermann JJ (2000) Feasibility of permanent implants for prostate cancer after previous radiotherapy in the true pelvis. Radiother Oncol 73:297–300

    Article  Google Scholar 

  • Beyer DC (1999) Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology 54:880–883

    Article  CAS  PubMed  Google Scholar 

  • Bianco FJ Jr, Scardino PT, Stephenson AJ et al (2005) Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 62:448–453

    Article  PubMed  Google Scholar 

  • Bomers JG, Yakar D, Overduin CG et al (2013) MR imaging-guided focal cryoablation in patients with recurrent prostate cancer. Radiology 268:451–460

    Article  PubMed  Google Scholar 

  • Bostwick DG, Egbert BM, Fajardo LF (1982) Radiation injury of the normal and neoplastic prostate. Am J Surg Pathol 6:541–551

    Article  CAS  PubMed  Google Scholar 

  • Brachman DG, Thomas T, Hilbe J, Beyer DC (2000) Failure-free survival following brachytherapy alone or external beam irradiation alone for T1–2 prostate tumors in 2222 patients: results from a single practice. Int J Radiat Oncol Biol Phys 48:111–117

    Article  CAS  PubMed  Google Scholar 

  • Breeuwsma AJ, Pruim J, van den Bergh AC, Leliveld AM, Nijman RJ, Dierckx RA, de Jong IJ (2010) Detection of local, regional, and distant recurrence in patients with psa relapse after external-beam radiotherapy using (11)C-choline positron emission tomography. Int J Radiat Oncol Biol Phys 77:160–164

    Article  PubMed  Google Scholar 

  • Burri RJ, Stone NN, Unger P, Stock RG (2010) Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 77:1338–1344

    Article  PubMed  Google Scholar 

  • Buyyounouski MK, Hanlon AL, Eisenberg DF, Horwitz EM, Feigenberg SJ, Uzzo RG et al (2005) Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer. Int J Radiat Oncol Biol Phys 63:1455–1462

    Article  PubMed  Google Scholar 

  • Cellini N, Morganti AG, Mattiucci GC et al (2002) Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning. Int J Radiat Oncol Biol Phys 53:595–599

    Article  PubMed  Google Scholar 

  • Chade DC, Shariat SF, Cronin AM et al (2011) Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol 60:205–210

    Article  PubMed  PubMed Central  Google Scholar 

  • Chade DC, Eastham J, Graefen M et al (2012) Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol 61:961–971

    Article  PubMed  Google Scholar 

  • Chen CP, Weinberg V, Shinohara K et al (2013) Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys 86:324–329

    Article  PubMed  Google Scholar 

  • Chin JL, Pautler SE, Mouraviev V et al (2001) Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 165:1937–1941

    Article  CAS  PubMed  Google Scholar 

  • Cox JD, Grignon DJ, Kaplan RS, Parsons JT, Schellhammer PF (1997) Consensus statement: guidelines for PSA following radiation therapy. American society for therapeutic radiology and oncology consensus panel. Int J Radiat Oncol Biol Phys 37:1035–1041

    Article  Google Scholar 

  • Crook J, Robertson S, Collin G et al (1993) Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 27:31–37

    Article  CAS  PubMed  Google Scholar 

  • Crook JM, Perry GA, Robertson S et al (1995) Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients. Urology 45:624–631

    Article  CAS  PubMed  Google Scholar 

  • Crook J, Bahadur Y, Robertson S et al (1997) Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma. Cancer 27:81–89

    Article  Google Scholar 

  • Crook J, Malone S, Perry G et al (2000) Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys 48:355–367

    Article  CAS  PubMed  Google Scholar 

  • Crouzet S, Murat FJ, Pommier P et al (2012) Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes. Radiother Oncol 105:198–202

    Article  PubMed  Google Scholar 

  • Das P, Chen MH, Valentine K et al (2002) Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce. Int J Radiat Oncol Biol Phys 54:698–702

    Article  PubMed  Google Scholar 

  • de Castro Abreu AL, Bahn D, Leslie S et al (2013) Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy. BJU Int 112:298–307

    Article  PubMed  Google Scholar 

  • De la Taille A, Hayek O, Benson MC et al (2000) Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience. Urology 55:79–84

    Article  PubMed  Google Scholar 

  • de Rooij M, Hamoen EH, Witjes JA, Barentsz JO, Rovers MM (2015) Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis. Eur Urol [epub ahead of print]

    Google Scholar 

  • Dutch Cancer Society (2010) SCK rapport kanker in Nederland, pp 141–145. www.kwfkankerbestrijding.nl/index.jsp?objectid=kwfredactie:6419

  • Eggener SE, Scardino PT et al (2007) Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 178:2260–2267

    Article  PubMed  Google Scholar 

  • Eisenberg ML, Shinohara K (2008) Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology 72:1315–1318

    Article  PubMed  Google Scholar 

  • Evangelista L, Zattoni F, Guttilla A et al (2013) Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis. Clin Nucl Med 38:305–314

    Article  PubMed  Google Scholar 

  • Freedland SJ, Humphreys EB, Mangold LA et al (2005) Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294:433–439

    Article  CAS  PubMed  Google Scholar 

  • Fütterer JJ, Briganti A, De Visschere P et al (2015) Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol 68:1045–1053

    Article  PubMed  Google Scholar 

  • Gelet A, Chapelon JY, Poissonnier L et al (2004) Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 63:625–629

    Article  PubMed  Google Scholar 

  • Grado GL, Collins JM, Kriegshauser JS et al (1999) Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 53:2–10

    Article  CAS  PubMed  Google Scholar 

  • Grignon DJ, Hammond EH (1995) College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Report of the prostate cancer working group. Arch Pathol Lab Med 119:1122–1126

    CAS  PubMed  Google Scholar 

  • Haider MA, Chung P, Sweet J et al (2008) Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 70:425–430

    Article  PubMed  Google Scholar 

  • Hamoen EH, de Rooij M, Witjes JA, Barentsz JO, Rovers MM (2015) Use of the prostate imaging reporting and data system (PI-RADS) for prostate cancer detection with multiparametric magnetic resonance imaging: a diagnostic meta-analysis. Eur Urol 67:1112–1121

    Article  PubMed  Google Scholar 

  • Heesakkers RA, Hövels AM, Jager GJ, van den Bosch HC, Witjes JA, Raat HP, Severens JL, Adang EM, van der Kaa CH, Fütterer JJ, Barentsz J (2008) MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 9:850–856

    Article  CAS  PubMed  Google Scholar 

  • Heidenreich A, Aus G, Bolla M et al (2008) EAU guidelines on prostate cancer. Eur Urol 53:68–80

    Article  PubMed  Google Scholar 

  • Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 65:467–479

    Article  CAS  PubMed  Google Scholar 

  • Hinnen KA, Monninkhof EM, Battermann JJ et al (2012) Prostate specific antigen bounce is related to overall survival in prostate brachytherapy. Int J Radiat Oncol Biol Phys 82:883–888

    Article  PubMed  Google Scholar 

  • Henríquez I, Sancho G, Hervás A et al (2014) Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity. Radiat Oncol 9:102–109

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hovels AM, Heesakkers RA, Adang EM et al (2008) The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 63:387–395

    Article  CAS  PubMed  Google Scholar 

  • Hsu CC, Hsu H, Pickett B et al (2013) Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer. Int J Radiat Oncol Biol Phys 85:370–377

    Article  PubMed  Google Scholar 

  • Huang WC, Kuroiwa K, Serio AM et al (2007) The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies. J Urol 177:1324–1329

    Article  PubMed  Google Scholar 

  • Huang SP, Bao BY, Wu MT et al (2011) Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapy. Prostate 71:1189–1197

    Article  CAS  PubMed  Google Scholar 

  • Izawa JI, Madsen LT, Scott SM et al (2002) Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol 20:2664–2671

    Article  PubMed  Google Scholar 

  • Jadvar H (2015) PSMA PET in prostate cancer. J Nucl Med 56:1131–1132

    Article  CAS  PubMed  Google Scholar 

  • Kalapurakal JA, Mittal BB, Sathiaseelan V (2001) Re-irradiation and external hyperthermia in locally advanced, radiation recurrent, hormone refractory prostate cancer: a preliminary report. Br J Radiol 74:745–751

    Article  CAS  PubMed  Google Scholar 

  • Kanthabalan A, Shah T, Arya M et al (2015) The FORECAST study – focal recurrent assessment and salvage treatment for radiorecurrent prostate cancer. Contemp Clin Trials [epub ahead of print]

    Google Scholar 

  • Kimura M, Mouraviev V, Tsivian M, Mayes JM, Satoh T, Polascik TJ (2010) Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU Int 150:191–201

    Article  CAS  Google Scholar 

  • Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A (2010) Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 28:126–131

    Article  PubMed  Google Scholar 

  • Klotz L, Vesprini D, Sethukavalan P et al (2015) Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 33:272–277

    Article  PubMed  Google Scholar 

  • Koutrouvelis P, Hendricks F, Lailas N et al (2003) Salvage reimplantation in patient with local recurrent prostate carcinoma after brachytherapy with three dimensional computed tomography-guided permanent pararectal implant. Technol Cancer Res Treat 2:339–344

    Article  PubMed  Google Scholar 

  • Kovacs G, Potter R, Loch T et al (2005) GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiother Oncol 74:137–148

    Article  PubMed  Google Scholar 

  • Lee B, Shinohara K, Weinberg V et al (2007) Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 67:1106–1112

    Article  PubMed  Google Scholar 

  • Lee KL, Adams MT, Motta J (2008) Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy. Brachytherapy 7:17–21

    Article  PubMed  Google Scholar 

  • Leibovici D, Chiong E, Pisters LL et al (2012) Pathological characteristics of prostate cancer recurrence after radiation therapy: implications for focal salvage therapy. J Urol 188:98–102

    Article  PubMed  Google Scholar 

  • Li YH, Elshafei A, Agarwal G, Ruckle H, Powsang J, Jones JS (2015) Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry. Prostate 75:1–7

    Article  PubMed  Google Scholar 

  • Lo K, Stock RG, Stone NN (2005) Salvage prostate brachytherapy following radiotherapy failure. Int J Radiat Oncol Biol Phys 63:S290–S291

    Article  Google Scholar 

  • Loening SA, Turner JW (1993) Use of percutaneous transperineal 198Au seeds to treat recurrent prostate adenocarcinoma after failure of definitive radiotherapy. Prostate 23:283–290

    Article  CAS  PubMed  Google Scholar 

  • Master VA, Shinohara K, Carroll PR (2004) Ferromagnetic thermal ablation of locally recurrent prostate cancer: prostate specific antigen results and immediate/intermediate morbidities. J Urol 172:2197–2202

    Article  PubMed  Google Scholar 

  • Menard C, Iupati D, Publicover J et al (2015) MR-guided prostate biopsy for planning of focal salvage after radiation therapy. Radiology 274:181–191

    Article  PubMed  Google Scholar 

  • Moman MR, Van der Poel HG, Battermann JJ, Moerland MA, van Vulpen M (2009) Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapy. Brachytherapy 9:119–125

    Article  PubMed  Google Scholar 

  • Moman MR, van den Berg CA et al (2010) Focal salvage guided by T2 weighted and dynamic contrast enhanced magnetic resonance imaging for prostate cancer recurrences. Int J Radiat Oncol Biol Phys 76:741–746

    Article  PubMed  Google Scholar 

  • Moore CM, Robertson NL, Arsanious N et al (2013) Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 63:125–140

    Article  PubMed  Google Scholar 

  • Morton GC, Hoskin PJ (2013) Brachytherapy: current status and future strategies – can high dose rate replace low dose rate and external beam radiotherapy? Clin Oncol (R Coll Radiol) 25:474–482

    Article  CAS  Google Scholar 

  • Mostofi F, Davis C, Sesterhenn I (1992) Pathology of carcinoma of the prostate. Cancer 70:235–253

    Article  CAS  PubMed  Google Scholar 

  • Murat FJ, Poissonnier L, Rabilloud M et al (2009) Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol 55(3):640–647

    Article  PubMed  Google Scholar 

  • Nguyen PL, Chen MH, D’Amico AV et al (2007a) Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study. Cancer 110:4185–4192

    Google Scholar 

  • Nguyen PL, D’Amico AV, Lee AK, Suh WW (2007b) Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer 110:1417–1428

    Article  PubMed  Google Scholar 

  • Nguyen PL, Chen MH, Clark JA, Cormack RA, Loffredo M, McMahon E, Nguyen AU, Suh W, Tempany CM, D’Amico AV (2009) Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer: a prospective phase II study. Brachytherapy 8:345–352

    Article  PubMed  PubMed Central  Google Scholar 

  • Nguyen PL, Alibhai SM, Basaria S et al (2015) Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol 67:825–836

    Article  CAS  PubMed  Google Scholar 

  • Onik G, Miessau M, Bostwick DG (2009) Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. J Clin Oncol 27:4321–4326

    Article  PubMed  Google Scholar 

  • Onur R, Littrup PJ, Pontes JE, Bianco FJ Jr (2004) Contemporary impact of transrectal ultrasound lesions for prostate cancer detection. J Urol 172:512–514

    Article  PubMed  Google Scholar 

  • Paparel P, Cronin AM, Savage C, Scardino PT, Eastham JA (2009) Oncologic outcome and patterns of recurrence after salvage radical prostatectomy. Eur Urol 55:404–410

    Article  PubMed  Google Scholar 

  • Peters M, Moman MR, van der Poel HG et al (2013) Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review. World J Urol 31:403–409

    Article  PubMed  Google Scholar 

  • Peters M, Maenhout M, van der Voort van Zyp JR et al. (2014) Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life. Radiother Oncol 112:77–82

    Article  PubMed  Google Scholar 

  • Peters M, Van der Voort van Zyp J, Hoekstra C et al (2015) Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints. Radiother Oncol 117(2):262–269

    Article  PubMed  Google Scholar 

  • Peters M, Hoekstra C, van der Voort van Zyp J et al (2016) Rectal dose constraints for salvage iodine-125 prostate brachytherapy. Brachytherapy 15:85–93

    Google Scholar 

  • Pisters LL, English SF, Scott SM et al (2000) Salvage prostatectomy with continent catheterizable urinary reconstruction: a novel approach to recurrent prostate cancer after radiation therapy. J Urol 163:1771–1774

    Article  CAS  PubMed  Google Scholar 

  • Pound CR, Brawer MK, Partin AW (2001) Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancer. Rev Urol 3:72–84

    CAS  PubMed  PubMed Central  Google Scholar 

  • Prestigiacomo AF, Stamey TA (1996) Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 Ng/ml range in male volunteers. J Urol 155:1977–1980

    Article  CAS  PubMed  Google Scholar 

  • Pucar D, Sella T, Schoder H (2008) The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgery. Curr Opin Urol 18:87–97

    Article  PubMed  Google Scholar 

  • Roach M III, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference. Int J Radiat Oncol Biol Phys 65:965–974

    Article  PubMed  Google Scholar 

  • Rouviere O, Valette O, Grivolat S et al (2004) Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor–correlation with biopsy findings. Urology 63:922–927

    Article  PubMed  Google Scholar 

  • Rybalov M, Ananias HJK, Hoving HD (2014) PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy. Int J Mol Sci 15:6046–6061

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sanderson KM, Penson DF, Cai J et al (2006) Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol 176:2025–2031

    Article  PubMed  Google Scholar 

  • Sasaki H, Kido M, Miki K et al (2013) Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy. Int J Urol 21:572–577

    Article  PubMed  Google Scholar 

  • Scardino PT (1983) The prognostic significance of biopsies after radiotherapy for prostatic cancer. Semin Urol 1:243–252

    CAS  PubMed  Google Scholar 

  • Sheets NC, Goldin GH, Meyer AM et al (2012) Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA 307:1611–1620

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Siddiqui MM, Rais-Bahrami S, Turkbey B et al (2015) Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313:390–397

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sivaraman A, Sanchez-Salas R, Barret E (2015) Transperineal template-guided mapping biopsy of the prostate. Int J Urol 22:146–151

    Article  PubMed  Google Scholar 

  • Spiess PE, Katz AE, Chin JL et al (2010) A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer. BJU Int 106:194–198

    Article  PubMed  Google Scholar 

  • Stephenson AJ, Scardino PT, Bianco FJ et al (2004) Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 172:2239–2243

    Article  PubMed  Google Scholar 

  • Tran H, Kwok J, Pickles T, Tyldesley S, Black PC (2014) Underutilization of local salvage therapy after radiation therapy for prostate cancer. Urol Oncol 32:701–706

    Article  PubMed  Google Scholar 

  • Umbehr MH, Muntener M, Hany T, Sulser T, Bachmann LM (2013) The role of 11C-choline and 18Ffluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis. Eur Urol 64:106–117

    Article  PubMed  Google Scholar 

  • Vaidya A, Soloway MS (2000) Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited. J Urol 164:1998–2001

    Article  CAS  PubMed  Google Scholar 

  • Valerio M, Anele C, Charman SC et al (2015) Transperineal template prostate mapping biopsies: an evaluation of different protocols in detection of clinically significant prostate cancer. BJU Int [epub ahead of print]

    Google Scholar 

  • Van den Bos W, Muller BG, de Bruin DM (2015) Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial design. Urol Oncol 33:495.e1–495.e7

    Article  Google Scholar 

  • Van der Heide UA, Dehnad H, Hofman P, Kotte ANTJ, Lagendijk JJW, Van Vulpen M (2007) Analysis of fiducial marker based position verification in the intensity-modulated radiotherapy of patients with prostate cancer. Radiother Oncol 82:38–45

    Article  PubMed  Google Scholar 

  • Van der Poel HG, Beetsma DB, van Boven H et al (2007) Perineal salvage prostatectomy for radiation resistant prostate cancer. Eur Urol 51:1565–1571

    Article  PubMed  Google Scholar 

  • Wallner KE, Nori D, Morse MJ et al (1990) 125iodine reimplantation for locally progressive prostatic carcinoma. J Urol 144:704–706

    Article  CAS  PubMed  Google Scholar 

  • Wang H, Vees H, Miralbell R, Wissmeyer M, Steiner C, Ratib O, Senthamizhchelvan S, Zaidi H (2009) 18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer. Radiother Oncol 93:220–225

    Article  CAS  PubMed  Google Scholar 

  • Ward JF, Sebo TJ, Blute ML et al (2005) Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol 173:1156–1160

    Article  PubMed  Google Scholar 

  • Ward JF, Pagliaro LC, Pisters LL et al (2008) Salvage therapy for radiorecurrent prostate cancer. Curr Probl Cancer 32(6):242–271

    Article  PubMed  Google Scholar 

  • Wenske S, Quarrier S, Katz AE (2013) Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery: long-term clinical, functional, and oncologic outcomes in a large cohort at a tertiary referral centre. Eur Urol 64:1–7

    Article  PubMed  Google Scholar 

  • Williams AK, Martinez CH, Lu C, Ng CK, Pautler SE, Chin JL (2011) Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer. Eur Urol 60:405–410

    Article  PubMed  Google Scholar 

  • Wong WW, Buskirk SJ, Schild SE et al (2006) Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation. J Urol 176:2020–2024

    Article  PubMed  Google Scholar 

  • Yamada Y, Kollmeier MA, Pei X et al (2014) A phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy. Brachytherapy 13:111–116

    Article  PubMed  Google Scholar 

  • Zagars GK, Pollack A (1997) Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer. Radiother Oncol 44:213–221

    Article  CAS  PubMed  Google Scholar 

  • Zelefsky MJ, Ben-Porat L, Scher HI et al (2005) Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer. J Clin Oncol 23:826–831

    Article  PubMed  Google Scholar 

  • Zelefsky MJ, Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC et al (2007) Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 67:327–333

    Article  PubMed  Google Scholar 

  • Zietman AL, Tibbs MK, Dallow KC et al (1996) Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate. Radiother Oncol 40:159–162

    Article  CAS  PubMed  Google Scholar 

  • Zumsteg ZS, Spratt DE, Romesser PB et al (2015) The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy. Eur Urol 67:1009–1016

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiotherapy, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584CX, The Netherlands

    Max Peters, Metha Maenhout, Steven Frank & Marco van Vulpen

Authors
  1. Max Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Metha Maenhout
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven Frank
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marco van Vulpen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Max Peters .

Editor information

Editors and Affiliations

  1. Department of Oncology, University of Tromso and Nordland Hospital, Bodo, Norway

    Carsten Nieder

  2. University Medical Center Groningen, Groningen, The Netherlands

    Johannes Langendijk

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Peters, M., Maenhout, M., Frank, S., van Vulpen, M. (2016). Prostate Cancer. In: Nieder, C., Langendijk, J. (eds) Re-Irradiation: New Frontiers. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/174_2016_56

Download citation

  • DOI: https://doi.org/10.1007/174_2016_56

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-41823-0

  • Online ISBN: 978-3-319-41825-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation